MedTrace Logo

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

NCT05120557 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2022-08-23

No results posted yet for this study

Summary

The main objective of the study is to determine the diagnostic performances of an ultraportable diagnostic ultrasound system for the assessment of liver fibrosis severity in patients with NASH, and to compare them to other non-invasive tests.

Conditions

Interventions

DEVICE

Ultrasound liver assessment

The intervention consists in an ultrasound exam performed with the ultrasound medical device subject of the research.

Sponsors & Collaborators

  • E-Scopics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2023-09-30
Completion
2023-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05120557 on ClinicalTrials.gov